Table 3 Echocardiographic measures in participants grouped by troponin elevation.

	cTnT >0.10 ng/ml	cTnT <0.10 ng/ml	cTnT >0.01 ng/ml	cTnT <0.01 ng/ml
	post‐race	post‐race	next day	next day
	(n = 6)*	(n = 32)†	(n = 9)‡	(n = 29)§
Stroke volume (ml)
Pre‐race	136 (27)	109 (23)	127 (33)	109 (21)
Post‐race	85 (23)	90 (22)	99 (25)	87 (20)
2–6 weeks	133 (21)	109 (27)	130 (24)	111 (28)
Ejection fraction (%)
Pre‐race	72 (5)	63 (8)	65 (9)	64 (8)
Post‐race	59 (9)	59 (8)	57 (8)	59 (8)
2–6 weeks	70 (2)	63 (7)	69 (4)	63 (8)
Cardiac output (l/min)
Pre‐race	7.9 (2.0)	6.4 (1.5)	7.6 (2.0)	6.4 (1.5)
Post‐race	6.9 (2.1)	7.3 (1.8)	8.1 (2.0)	7.0 (1.7)
2–6 weeks	7.5 (1.8)	6.3 (1.8)	7.8 (2.0)	6.3 (1.8)
Wall motion score
Pre‐race	16.0 (0)	16.4 (1.8)	16.0 (0)	16.4 (1.9)
Post‐race	16.8 (1.6)	17.8 (2.1)	17.4 (2.2)	17.7 (2.0)
2–6 weeks	16.3 (0.6)	16.1 (0.3)	16.3 (0.6)	16.1 (0.3)
Global LVF
Pre‐race	0 (0)	0 (0)	0 (0)	0 (0)
Post‐race	−1.1 (0.8)	−0.48 (0.60)	−0.83 (0.8)	−0.50 (0.62)
2–6 weeks	0 (0)	−0.06 (0.17)	0 (0)	0.06 (0.16)

Data expressed as mean (SD).

*4 of these participants underwent echocardiography two to six weeks post‐race.

†17 of these participants underwent echocardiography two to six weeks post‐race.

‡3 of these participants underwent echocardiography two to six weeks post‐race.

§18 of these participants underwent echocardiography two to six weeks post‐race.

cTnT, cardiac troponin T; LVF, left ventricular function.